Argon AI has introduced it secured $5.5 million in seed funding.
Crosslink Capital and Wireframe Ventures co-led the spherical, with participation from Y Combinator, Pioneer Fund and different traders.
WHAT IT DOES
Argon AI presents a platform aimed toward serving to life sciences corporations automate data-intensive workflows. Its AI assistants assist with repetitive, handbook and rote duties throughout scientific and business work.
The AI-enabled platform additionally unifies varied codecs of trade information, together with structured tables, PDFs, slide decks and pictures, throughout totally different information sources akin to medical literature, firm info and convention proceedings.
The corporate will use the funds for product enhancements, crew growth and buyer growth.
“Each business or scientific technique determination is constructed on high of fragmented, outdated or hard-to-access info,” Samy Danesh, CEO and cofounder of Argon AI, stated in an announcement.
“We’re constructing Argon to make data as accessible and actionable as your inbox and to free life sciences groups to give attention to bringing new therapies to sufferers.”
MARKET SNAPSHOT
Different corporations within the information workflow house embrace Plenful, a workflow-automation platform for pharmacy and healthcare operations, which in 2024 secured $17 million in Collection A funding lower than a yr after launching with $9 million in funding.
Plenful presents pharmacy technicians a no-code, AI-enabled automation software for handbook and administrative workflows, together with assist with doc information entry for pharmacy income cycle, referral orders, auditing and financial savings identification.
The corporate used the funds to scale its advertising and marketing, gross sales and product growth efforts.
That very same yr, SamaCare, a workflow platform for suppliers providing specialty medicine, introduced it secured $17 million in an oversubscribed Collection B funding spherical.
The corporate presents a cloud-based workflow automation platform to help suppliers in acquiring prior authorization for specialty drug drugs, verifying enrollment and checking advantages.
It additionally works with pharmaceutical corporations to offer information analytics to assist enhance entry to their therapies.
The corporate used the funds to increase its Script-to-Remedy Working System, which can leverage AI for administrative duties, create a post-prescription workflow, accumulate information insights and improve collaboration between suppliers’ workplaces.
